
                <!DOCTYPE html>
                <html lang="en">
                <head>
                    <meta charset="UTF-8">
                    <meta name="viewport" content="width=device-width, initial-scale=1.0">
                    <title>Small Business - Cordele Dispatch | Cordele Dispatch</title>
                </head>
                <body>
                    <h1>Small Business - Cordele Dispatch | Cordele Dispatch</h1>
                    <h2>Headings:</h2>
                    <h1>FDA Roundup: November 5, 2024</h1><h1>FDA Roundup: November 5, 2024</h1>
                    <h2>Paragraphs:</h2>
                    <p>PR Newswire</p><p>SILVER SPRING, Md., Nov. 5, 2024</p><p>SILVER SPRING, Md.,Nov. 5, 2024/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:</p><p>"Today's action brings to market the first therapeutic option for adult patients with dry AMD," saidMalvina Eydelman, M.D., director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices at the FDA's Center for Devices and Radiological Health. "This authorization reinforces FDA's commitment to assuring access to innovative, safe and effective medical devices to treat high-prevalence, degenerative conditions."</p><p>The Valeda Light Delivery System uses three light emitting diodes that generate light at different wavelengths to provide treatment to the patient's eye. Treatment with the device after approximately two years can provide an average improvement in vision equivalent to around one line on an eye chart.</p><p>Additional Resources:</p><p>Media Contact:FDA Office of Media Affairs, 301-796-4540Consumer Inquiries: 888-INFO-FDA</p><p>The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.</p><p></p><p>View original content to download multimedia:https://www.prnewswire.com/news-releases/fda-roundup-november-5-2024-302296996.html</p><p>SOURCE  U.S. Food and Drug Administration</p>
                </body>
                </html>
            